(MedPage Today) — The direct-acting antiviral glecaprevir/pibrentasvir (Mavyret) was highly effective and well tolerated in adults with acute hepatitis C virus (HCV) infection, according to results from a multicenter phase IIIb trial.
Among 286…
Source link : https://www.medpagetoday.com/gastroenterology/hepatitis/118748
Author :
Publish date : 2025-11-26 18:06:00
Copyright for syndicated content belongs to the linked Source.
